NR 603 Dementia – 50+ Exam Questions with Answers – Alzheimer’s, MCI, Lewy Body, SSRIs – Chamberlain University

This document is a comprehensive exam preparation resource for NR 603, focusing on dementia-related disorders, tailored for the 2025/2026 academic year at Chamberlain University. It contains over 50 accurately answered multiple-choice questions covering the most critical concepts and clinical guidelines related to dementia assessment, diagnosis, and management. The content spans the full spectrum of dementia types, including Alzheimer’s disease, vascular dementia, Lewy body dementia, and pseudodementia (depression-related cognitive decline). Students will review hallmark pathologies such as amyloid plaques, neurofibrillary tangles, and lacunar infarcts. The document also details the diagnostic criteria for mild cognitive impairment (MCI), a precursor to dementia, and clearly distinguishes between amnestic and nonamnestic subtypes. Students will benefit from in-depth explanations of the three stages of Alzheimer’s, the pharmacologic management of dementia (including cholinesterase inhibitors and NMDA receptor antagonists like memantine), and non-drug interventions that support cognitive function. It also covers key laboratory and imaging diagnostics, black box warnings for antipsychotics, and preferred antidepressants (SSRIs) for comorbid depression in dementia patients. This document is highly relevant for: Family Nurse Practitioner (FNP) students Adult-Gerontology Primary or Acute Care NP students MSN and BSN students studying neurology, geriatrics, or psychiatric nursing AANP and ANCC board exam candidates Healthcare professionals reviewing dementia care guidelines It is an excellent resource for clinical exam prep, board review, or as a learning companion during neurology and gerontology modules. Keywords: dementia, NR 603, Alzheimer’s disease, Lewy body dementia, mild cognitive impairment, MCI, vascular dementia, cholinesterase inhibitors, NMDA receptor antagonists, memantine, SSRIs, depression in dementia, pseudodementia, cognitive decline, neurodegenerative disease, dementia staging, Parkinson overlap, patient education, Chamberlain University